Avience Biomedicals Ltd vs Park Medi World Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Park Medi World Ltd changed from 31.7 on March 2026 to 0 on March 2023 . This represents a CAGR of -100.00% over 4 years The Market Cap of Avience Biomedicals Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Park Medi World Ltd changed from ₹ 8191 crore on March 2026 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 4 years The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Park Medi World Ltd for the Jun '26 is ₹ 483.36 crore as compare to the Mar '26 revenue of ₹ 467.92 crore. This represent the growth of 3.3% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Park Medi World Ltd for the Jun '26 is ₹ 133.73 crore as compare to the Mar '26 ebitda of ₹ 134.87 crore. This represent the decline of -0.85% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Park Medi World Ltd changed from ₹ 45.65 crore to ₹ 88.59 crore over 7 quarters. This represents a CAGR of 46.06% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Park Medi World Ltd changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Park Medi World Ltd

Park Medi World Quarterly Result Overview Park Medi World quarterly results present a clear summary of financial performance across different reporting periods.
Investors can review revenue, profit, and overall business trends without studying detailed financial statements. Park Medi World quarterly results date helps track when each financial update is released during the year.
The overview shows how the company performs under changing business conditions and the market environment. Key Metrics of Park Medi World Quarterly Result Here are the main metrics typically covered: 1.
Revenue Revenue shows the total income generated from business activities during the reporting period.
Performance changes in quarterly results, such as Park Medi World Q3 results, may reflect seasonal demand and business cycles. 2.

FAQs for the comparison of Avience Biomedicals Ltd and Park Medi World Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Park Medi World Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Park Medi World Ltd is 9,308 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Park Medi World Ltd?

The stock performance of Avience Biomedicals Ltd and Park Medi World Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Park Medi World Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Park Medi World Ltd stock price is INR ₹215.5.

How do dividend payouts of Avience Biomedicals Ltd and Park Medi World Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Park Medi World Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.